Are immune checkpoint inhibitors a valid option for papillary renal cell carcinoma? A multicentre retrospective study
Manon De Vries-Brilland, Marine Gross‐Goupil, Valérie Seegers, Elouen Boughalem, Benoit Beuselinck, Constance Thibault, Christine Chevreau, Sylvain Ladoire, Philippe Barthélémy, Sylvie Négrier, Delphine Borchiellini, Olivier Huillard, Lionnel Geoffrois, Gwénaëlle Gravis, Carolina Saldana, Antoine Thiery-Vuillemin, Bernard Escudier, Alain Ravaud, Laurence Albigès
Topics & Concepts
DiscontinuationMedicineInternal medicineAdverse effectPapillary renal cell carcinomasOncologyClinical endpointRenal cell carcinomaRetrospective cohort studyHazard ratioProgressive diseaseConfidence intervalGastroenterologyDiseaseClinical trialRenal cell carcinoma treatmentCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosis